Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
Subscribe to our weekly newsletter.
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
Leonard Freedman, president of the Global Biological Standards Institute, discusses the causes of irreproducible science and his latest effort to spread best practices.
An analysis of a collection of open-access datasets quantifies their benefit to the scientific community.
Nature Plants explains how it handled a manuscript coauthored by Patrice Dunoyer, a biologist with multiple retractions to his name.
Nearly 1,000 signatories are asking the National Institutes of Health to reinstitute the Grant Support Index proposal.
The Chinese government finds almost 500 researchers guilty of misconduct in relation to a recent spate of retractions from a cancer journal.
Experts debate how best to point researchers to reputable publishers and steer them away from predatory ones.
Computational scientists develop a system for spotting data overdue for public release, and end up getting hundreds of open-access datasets corrected.
We suggest a centralized facility for submitting to journals—one that would benefit scientists and not only publishers.
When firing Allen Braun, the NIDCD also barred his colleagues from publishing data collected over a 25-year period.
As the NIH questions the place of preprints in grant applications, the U.K.’s MRC encourages scientists to submit non-peer-reviewed works for consideration.
Three UK neuroscientists jointly win the €1 million European Brain Prize for their work on memory.
Panelists and attendees at the American Society for Cell Biology annual meeting considered the future of peer review and journal impact factors.